Pierluigi Francesco Salvo

9PUBLICATIONS
23CO-AUTHORS
Innate immunityRegenerative medicine (incl. stem cells)Epidemiological methodsGene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 07, 2026
Dengue-specific T-cell memory following natural infection: a comparative analysis between people living with HIV and HIV-negative individuals.

|Sep 27, 2025
Real-World Experience with Long-Acting Injectable Cabotegravir/Rilpivirine in HIV Patients with Unsuppressed Viral Load.

Marcello Trizzino, Luca Pipitò, Pierluigi Francesco Salvo

|Aug 28, 2025
Understanding Attitudes Toward Zoster Vaccination in the Hospital Setting: A Multidisciplinary Model to Contrast Vaccine Hesitancy in Fragile Patients-A Prospective Longitudinal Observational Study.

Luca Regazzi, Silvia Martinelli, Federica Rizzo

|Feb 05, 2025
Impact of HBV serological status on HIV virological efficacy of two-drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with HIV switching to lamivudine/dolutegravir.

Pierluigi Francesco Salvo, Arturo Ciccullo, Elena Visconti

|May 27, 2023
Changes in Metabolic Profile in PLWHIV Switching to Doravirine-Based Regimen.

Valentina Iannone, Rosa Anna Passerotto, Francesco Lamanna

|Mar 30, 2023
Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype.

Pierluigi Francesco Salvo, Damiano Farinacci, Arturo Ciccullo

Pageof 2

Frequent Collaborators

2 joint publications

Damiano Farinacci

2 joint publications

Francesca Lombardi

2 joint publications

Arturo Ciccullo

2 joint publications

Gianmaria Baldin